A retrospective study to evaluate the efficacy and safety of Brentuximab-vedotin in patients with Hodgkin's lymphoma progressing or relapsing after allogeneic stem cell transplantation.
Phase of Trial: Clinical Phase Unknown
Latest Information Update: 28 Nov 2015
At a glance
- Drugs Brentuximab vedotin (Primary)
- Indications Hodgkin's disease
- Focus Therapeutic Use
- 28 Nov 2015 New trial record